The global melatonin supplements market is projected to grow from $3.3 billion in 2025 to $13.1 billion by 2035, fueled by shifting consumer behavior toward preventive health care and non-prescription sleep aids.
According an industry outlook from Future Market Insights (FMI), leading wellness segments, including insomnia management and stress relief, are driving a 14.9% CAGR as the industry transitions from niche adoption to mainstream integration.
As modern lifestyles grapple with rising stress levels, excessive screen exposure, and disrupted circadian rhythms, melatonin has moved beyond niche wellness circles. While North America and Europe remain established hubs for high-quality, clinically tested supplements, the Asia-Pacific region is emerging as the fastest-growing frontier.
According to the report, by 2035, the industry is anticipated to reach a state of "predictable growth," characterized by established international standards for labeling, dosage limits, and distribution. As repeat consumers become the largest market base, the focus for top-tier manufacturers will shift from customer acquisition to long-term retention through product differentiation.